NIH-funded research P01 program project

Perimenopause, brain aging, and Alzheimer's risk

Official title: Perimenopause in Brain Aging and Alzheimer's Disease

Funded at University of Arizona · NIH-11129666 · Data updated 2026-11-12

This program explores how hormonal and metabolic changes during perimenopause affect brain aging and Alzheimer's risk for middle-aged women, with special attention to APOE-e4.

Quick facts

Grant typeP01 program project
Study typeNIH-funded research
Funding institutionUniversity of Arizona
NIH-funded
Lab location1 site (Tucson, United States)
Project startAugust 15, 2006
Project endMay 31, 2027
Funding year2025
Award (this year)$2,919,843
NIH project number5P01AG026572-20
Project IDNIH-11129666 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates are women in midlife who are in perimenopause or roughly ages 40–60, especially those with a family history of Alzheimer's or who carry the APOE-e4 gene.

Less likely to help

Men, people already living with advanced Alzheimer's dementia, or women well outside the perimenopausal age range are unlikely to benefit directly from participation.

What this research studies

You would be followed through the perimenopausal transition with brain scans, blood tests, cognitive testing, and other health measures to spot early changes linked to Alzheimer’s. The team combines imaging, metabolic and immune markers, genetic information (including APOE status), and population data to find patterns that predict higher risk. Their goal is to turn those patterns into personalized prevention or delay strategies for women at midlife. The research is led by investigators at the University of Arizona focusing on mechanisms that start during perimenopause.

Why it matters

Potential benefit: If successful, this work could lead to personalized prevention approaches that delay or prevent Alzheimer's in women by targeting midlife biological changes.

How similar studies have gone: Earlier imaging and biomarker studies have linked perimenopause to brain changes and shown APOE modifies Alzheimer's risk, but turning those findings into proven prevention strategies is still an emerging area.

Where this research is happening

  • University of Arizona
    Tucson, United States
    Active

Researchers

  • Principal investigator: Brinton, Roberta Eileen — University of Arizona
  • Study coordinator: Brinton, Roberta Eileen

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.